Xanthohumol Inhibits Notch Signaling and Induces Apoptosis in Hepatocellular Carcinoma

作者: Selvi Kunnimalaiyaan , Kevin M. Sokolowski , Mariappan Balamurugan , T. Clark Gamblin , Muthusamy Kunnimalaiyaan

DOI: 10.1371/JOURNAL.PONE.0127464

关键词:

摘要: Despite improvement in therapeutic strategies, median survival advanced hepatocellular carcinoma (HCC) remains less than one year. Therefore, molecularly targeted compounds with toxic profiles are needed. Xanthohumol (XN), a prenylated chalcone has been shown to have anti-proliferative effects various cancers types vitro. XN treatment healthy mice and humans yielded favorable pharmacokinetics bioavailability. we determined study the of understand mechanism its action HCC. The on panel HCC cell lines were assessed for viability, colony forming ability, cellular proliferation. Cell lysates analyzed pro-apoptotic (c-PARP cleaved caspase-3) anti-apoptotic markers (survivin, cyclin D1, Mcl-1). concentrations 5μM above significantly reduced ability also confluency all four studied. Furthermore, growth suppression due apoptosis was evidenced by increased expression proteins. Importantly, inhibited Notch signaling pathway as decrease Notch1 HES-1 Ectopic cells reverses effect compared control. Taken together these results suggested that mediated is appeared be inhibition pathway. our findings warrants further studies potential agent

参考文章(44)
Song Zhang, Yang Yang, Zhenxing Liang, Weixun Duan, Jian Yang, Juanjuan Yan, Ning Wang, Wenqiang Feng, Meiling Ding, Yongzhan Nie, Zhenxiao Jin, Silybin-Mediated Inhibition of Notch Signaling Exerts Antitumor Activity in Human Hepatocellular Carcinoma Cells PLoS ONE. ,vol. 8, pp. e83699- ,(2013) , 10.1371/JOURNAL.PONE.0083699
L. Delmulle, T. Vanden Berghe, D. De Keukeleire, P. Vandenabeele, Treatment of PC-3 and DU145 prostate cancer cells by prenylflavonoids from hop (Humulus lupulus L.) induces a caspase-independent form of cell death. Phytotherapy Research. ,vol. 22, pp. 197- 203 ,(2008) , 10.1002/PTR.2286
Marcus Alexander Wörns, Peter Robert Galle, Novel inhibitors in development for hepatocellular carcinoma. Expert Opinion on Investigational Drugs. ,vol. 19, pp. 615- 629 ,(2010) , 10.1517/13543781003767418
Sun Young Kim, Ik-Soo Lee, Aree Moon, 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells Chemico-Biological Interactions. ,vol. 203, pp. 565- 572 ,(2013) , 10.1016/J.CBI.2013.03.012
Shinichi Yabuuchi, Shweta G Pai, Nathaniel R Campbell, Roeland F De Wilde, Elizabeth De Oliveira, Preethi Korangath, Mirte M Streppel, Zeshaan A Rasheed, Manuel Hidalgo, Anirban Maitra, NV Rajeshkumar, None, Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer Cancer Letters. ,vol. 335, pp. 41- 51 ,(2013) , 10.1016/J.CANLET.2013.01.054
Liang Zhou, Ning Zhang, Wenjie Song, Nan You, Qingjun Li, Wei Sun, Yong Zhang, Desheng Wang, Kefeng Dou, The Significance of Notch1 Compared with Notch3 in High Metastasis and Poor Overall Survival in Hepatocellular Carcinoma PLoS ONE. ,vol. 8, pp. e57382- ,(2013) , 10.1371/JOURNAL.PONE.0057382
QIAN SUN, RONGHUA WANG, YAN WANG, JING LUO, PENG WANG, BIN CHENG, Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma. Oncology Reports. ,vol. 31, pp. 933- 939 ,(2014) , 10.3892/OR.2013.2917
Marcus Alexander Wörns, Arndt Weinmann, Kerstin Pfingst, Carla Schulte-Sasse, Claudia-Martina Messow, Henning Schulze-Bergkamen, Andreas Teufel, Marcus Schuchmann, Stephan Kanzler, Christoph Düber, Gerd Otto, Peter Robert Galle, Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis. Journal of Clinical Gastroenterology. ,vol. 43, pp. 489- 495 ,(2009) , 10.1097/MCG.0B013E31818DDFC6
Marcus A. Wörns, Sandra Koch, Ina M. Niederle, Jens U. Marquardt, Marc Nguyen-Tat, Thomas Gamstätter, Marcus Schuchmann, Henning Schulze-Bergkamen, Peter R. Galle, Arndt Weinmann, The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib Digestive and Liver Disease. ,vol. 45, pp. 408- 413 ,(2013) , 10.1016/J.DLD.2012.10.010
Jessica G. Drenzek, Nicole L. Seiler, Renata Jaskula-Sztul, Margaret M. Rausch, Stephen L. Rose, Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines. Gynecologic Oncology. ,vol. 122, pp. 396- 401 ,(2011) , 10.1016/J.YGYNO.2011.04.027